October 22, 2007 — SenoRx Inc. recently announced it received 510(k) clearance from the FDA for its SenoSonix System, an integration of its EnCor breast biopsy system with an ultrasound imaging system.
The device incorporates SenoRx's proprietary EnCor vacuum-assisted biopsy technologies with an ultrasound system developed and sold by Ultrasonix Medical Corp.
Ultrasonix launched its Sonix series of Smart Ultrasound systems in 2005 and has placed over 1,000 systems worldwide. Launching its flagship EnCor system in November 2005, SenoRx currently has an installed base of more than 400 of its breast biopsy systems in the U.S. and Canada.
For more information: www.senorx.com and www.ultrasonix.com
October 30, 2026 
